New Atlas

First US at-home depression kit on its way after trial shows relief in weeks

In a major shift for how mental health conditions might be treated, the US Food and Drug Administration (FDA) has approved ...
Medscape

At-Home Transcranial Direct Current Stimulation Improves Fibromyalgia Pain

A noninvasive, home-based brain treatment with transcranial direct current stimulation (tDCS) can reduce pain severity, improve pain-related disability, and enhance endogenous pain modulation in women ...
Medscape

FDA OKs First At-Home Brain Stimulation Device for Depression

The FDA has approved the first at -home brain-stimulation device for adults with major depressive disorder (MDD). The FL-100 transcranial direct-current stimulation (tDCS) system (Flow Neuroscience) ...
Healio

Transcranial direct current stimulation beneficial for moderate to severe depression

Please provide your email address to receive an email when new articles are posted on . High-definition transcranial direct current stimulation was well tolerated with mild adverse effects. The ...
WFMZ-TV

FDA Clears Home Brain-Stimulation Device to Help Treat Depression

The U.S. Food and Drug Administration cleared Flow Neuroscience’s at-home electrical stimulation headset for adults with moderate-to-severe depression A trial of 174 people found the device led to ...
EurekAlert!

Transcranial direct current stimulation device (IMAGE)

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert ...
Seeking Alpha

Nexalin Technology Awarded Key Patent Related to its Non-Invasive, Frequency-Based Deep-Brain Stimulation Device – the Transcranial Alternating Current Dynamic Frequency ...

HOUSTON, TX, Jan. 23, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (NXL) (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) today announced that the United States Patent and Trademark Office ...